[HTML][HTML] Parkinson disease-associated cognitive impairment
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Author Correction: Parkinson disease-associated cognitive impairment (Nature Reviews Disease Primers,(2021), 7, 1,(47), 10.1038/s41572-021-00280-3)
D Aarsland, L Batzu… - Nature …, 2021 - researchinformation.amsterdamumc …
Author Correction: Parkinson disease-associated cognitive impairment (Nature Reviews
Disease Primers, (2021), 7, 1, (47), 10.1038/s41572-021-00280-3) — Amsterdam UMC …
Disease Primers, (2021), 7, 1, (47), 10.1038/s41572-021-00280-3) — Amsterdam UMC …
[引用][C] Parkinson disease-associated cognitive impairment
D Aarsland, L Batzu, GM Halliday… - Nature Reviews …, 2021 - cir.nii.ac.jp
Parkinson disease-associated cognitive impairment | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[PDF][PDF] Parkinson disease-associated cognitive impairment
D Aarsland, L Batzu, GM Halliday, GJ Geurtsen… - 2021 - ore.exeter.ac.uk
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Parkinson disease-associated cognitive impairment.
D Aarsland, L Batzu, GM Halliday… - Nature reviews …, 2021 - europepmc.org
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Parkinson disease-associated cognitive impairment
D Aarsland, L Batzu, GM Halliday… - Nature reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Parkinson disease-associated cognitive impairment
D Aarsland - Nature Review Disease Primers, 2021 - kclpure.kcl.ac.uk
Parkinson disease (PD) is the second most common neurodegenerative disorder, affects>
1% of the population≥ 65 years of age and the prevalence is set to double by 2030. In …
1% of the population≥ 65 years of age and the prevalence is set to double by 2030. In …
[HTML][HTML] Parkinson disease-associated cognitive impairment
D Aarsland, L Batzu, GM Halliday… - Nature Reviews …, 2021 - nature.com
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
[引用][C] Author Correction: Parkinson disease-associated cognitive impairment
D Aarsland, L Batzu, GM Halliday… - Nature reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
Author Correction: Parkinson disease-associated cognitive impairment Author Correction:
Parkinson disease-associated cognitive impairment Nat Rev Dis Primers. 2021 Jul 13;7(1):53 …
Parkinson disease-associated cognitive impairment Nat Rev Dis Primers. 2021 Jul 13;7(1):53 …
[引用][C] Author Correction: Parkinson disease-associated cognitive impairment.
D Aarsland, L Batzu, GM Halliday… - Nature reviews …, 2021 - europepmc.org